NCT05100368View on ClinicalTrials.gov

The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 2, 2021

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions
Sarcoma, Ewing
Interventions
OTHER

patients

Patients with Ewing's Sarcoma and osteosarcoma with established diagnosis

Trial Locations (1)

40136

Istituto Ortopedico Rizzoli, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER

NCT05100368 - The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma | Biotech Hunter | Biotech Hunter